Activity Trackers Can Predict RA Flares
Activity Trackers Can Predict RA Flares jjcush@gmail.com Thu, 10/02/2025 – 15:07
RheumNow
October 2025
Google News
As Roche/Genentech’s Obinutuzumab (Gazyva) Nears FDA Decision, Spherix Global …
Authored by the Spherix rheumatology insights team with senior contribution from Michelle Petri, MD, Professor of Medicine at Johns Hopkins
RheumNow
Challenges diagnosing lung disease and ILD in pediatric patients Children with juvenile idiopathic inflammatory myosit
Challenges diagnosing lung disease and ILD in pediatric patients Children with juvenile idiopathic inflammatory myosit https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 10/02/2025 –
RheumNow
2019 National Health Survey of 87,678, 21% had chronic back pain (cLBP). cLBP had more Multimorbidity 62.1%, worse activ
2019 National Health Survey of 87,678, 21% had chronic back pain (cLBP). cLBP had more Multimorbidity 62.1%, worse activ https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Google News
2025 Guidelines: Management of Differentiated Thyroid Cancer – YouTube
… Carcinoma Care Strategies. Medscape New 73 views · 21:29 · Go to channel · Do I need Prednisone? A
Google News
Real-world sex differences in treatment persistence and reasons for discontinuation in …
The Rheumatic Disease Comorbidity Index (RDCI) is used to quantify the burden of comorbid conditions in patients with rheumatic diseases
The Rheumatologist
Benefits of Early Initiation of Biologic DMARDs in pJIA
The early initiation of biologic disease-modifying anti-rheumatic drugs (DMARDs) may reduce the overall disease burden in patients with polyarticular juvenile
RheumNow
RheumNow is LIVE from #ACR25 Oct 24–29. KOL perspective videos, clinical-trial highlights, daily recaps & live str
RheumNow is LIVE from #ACR25 Oct 24–29. KOL perspective videos, clinical-trial highlights, daily recaps & live str https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
Current Opinion in Rheumatology
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden
Purpose of review Assessing the impact of active therapy on how patients ‘feel and function’ is considered a necessary requirement
Current Opinion in Rheumatology
Unraveling the relationship between disordered sleep and systemic sclerosis outcomes
Purpose of review This review aimed to synthesize the current knowledge regarding the prevalence, underlying mechanisms, and clinical implications of
Current Opinion in Rheumatology
Harnessing artificial intelligence to advance insights in systemic sclerosis skin and lung disease
Purpose of review The purpose of this review is to summarize the uses of artificial intelligence for advancing systemic sclerosis
Current Opinion in Rheumatology
Gastrointestinal manifestations of systemic sclerosis: current approaches and emerging therapies
Purpose of review This review highlights recent advances in the understanding and management of gastrointestinal manifestations in systemic sclerosis (SSc).
Current Opinion in Rheumatology
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications
Purpose of review This review explores the evolving understanding of vascular dysfunction in systemic sclerosis (SSc), from early endothelial injury
Current Opinion in Rheumatology
Targeting inflammation, fibrosis, and vascular dysfunction in systemic sclerosis: the role of diet and complementary and alternative medicine
Purpose of review Patients with systemic sclerosis (SSc) often seek advice regarding diet including functional foods, and complementary and alternative
Current Opinion in Rheumatology
Targeted therapies in systemic sclerosis: a narrative review of novel drugs in clinical trials
Purpose of review Systemic sclerosis (SSc) remains a therapeutic challenge, with conventional immunosuppressive strategies showing inconsistent effects and no disease
Current Opinion in Rheumatology
Fueling fibrosis: metabolic dysregulation in systemic sclerosis
Purpose of review This review examines how metabolic reprogramming drives fibrosis and immune dysregulation in systemic sclerosis (SSc), emphasizing the
Current Opinion in Rheumatology
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype
Purpose of review To synthesize current knowledge on the genetic, immunopathogenic, and clinical presentations of systemic sclerosis (SSc) and primary
Google News
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
… Rheumatology and Clinical Immunology at Charité – Universitätsmedizin Berlin, Germany. … Rheumatic Drugs (DMARDs). Giant Cell Arteritis (GCA): …
RheumNow
Retrospective study of 137 pts w/ Usual interstitial pneumonia (UIP) w/ myositis Abs testing. 11% MSA+. & more like
Retrospective study of 137 pts w/ Usual interstitial pneumonia (UIP) w/ myositis Abs testing. 11% MSA+. & more like https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Google News
The effect of metformin in clinical studies on knee osteoarthritis: An updated systematic …
Front. Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1652732 …
Google News
As Roche/Genentech’s Obinutuzumab (Gazyva) Nears FDA – GlobeNewswire
“The SLE/LN market represents one of the most complex and competitive autoimmune landscapes,” said Sawyer May, Director, Rheumatology at Spherix.
Google News
STING-driven necroptosis linked to autoinflammatory disease | Nature Reviews Rheumatology
Research reveals that the cellular sensor protein STING induces necroptotic inflammation, and that this mechanism underlies inflammatory disease …
Nature Reviews Rheumatology
STING-driven necroptosis linked to autoinflammatory disease
Nature Reviews Rheumatology, Published online: 02 October 2025; doi:10.1038/s41584-025-01315-9 Findings demonstrate that STING mediates necroptosis in the context of autoinflammatory
RheumNow
ILD in Juvenile Dermatomyositis: Moving Toward Better Outcomes
ILD in Juvenile Dermatomyositis: Moving Toward Better Outcomes Charalampia.Pa… Thu, 10/02/2025 – 08:00
Google News
A case of SARS-CoV-2 infection during the course of SLE difficult to differentiate NPSLE … – PubMed
Affiliation. 1 Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan. PMID …
Google News
Intestinal microbial signature impacts interstitial lung disease in systemic sclerosis – Healio
Congress of Clinical Rheumatology. Disclosures: McLain reports no relevant financial disclosures. Published by: healio rheumatology logo. Sources …